Newcells Biotech Limited's Ophthalmology Business
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Newcells Biotech Limited's Ophthalmology Business - overview
Location
-, -, UK
Primary Industry
Biotechnology
About
Based in the UK, Newcells Biotech Limited's Ophthalmology Business specializes in developing vitro retinal models to enhance drug discovery, efficacy testing, and safety assessment for ophthalmic diseases. In February 2026, Axol Bioscience Ltd. , a portfolio company of Calculus Capital and BroadOak Capital Partners, acquired Newcells Biotech Limited's Ophthalmology Business. Newcells Biotech Limited's Ophthalmology Business offers platforms encompass advanced retinal organoids and 2D retinal pigment epithelium (RPE) models designed to support preclinical research and translational drug development.
The business includes facilities and intellectual property related to supply of proprietary iPSC-derived products and ophthalmology research services to biopharma, biotechnology and CRO customers across Europe and the United States.
Current Investors
Axol Bioscience Ltd.
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Optometrists & Opticians Products and Services, Pharmaceutical Research & Development
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Newcells Biotech Limited's Ophthalmology Business - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Corporate Carve Out | Completed | Newcells Biotech Limited's Ophthalmology Business | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.